TY - GEN
T1 - Erratum
T2 - Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))
AU - Miró, Guadalupe
AU - Petersen, Christine
AU - Cardoso, Luís
AU - Bourdeau, Patrick
AU - Baneth, Gad
AU - Solano-Gallego, Laia
AU - Pennisi, Maria Grazia
AU - Ferrer, Lluís
AU - Oliva, Gaetano
N1 - Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2018/5
Y1 - 2018/5
N2 - The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.
AB - The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.
UR - https://www.scopus.com/pages/publications/85034850826
U2 - 10.1016/j.pt.2017.11.003
DO - 10.1016/j.pt.2017.11.003
M3 - Other contribution
C2 - 29174223
AN - SCOPUS:85034850826
VL - 34
T3 - Trends in Parasitology
ER -
